157 related articles for article (PubMed ID: 20624907)
1. Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.
Tomoyasu T; Tabata A; Hiroshima R; Imaki H; Masuda S; Whiley RA; Aduse-Opoku J; Kikuchi K; Hiramatsu K; Nagamune H
Infect Immun; 2010 Sep; 78(9):4012-21. PubMed ID: 20624907
[TBL] [Abstract][Full Text] [Related]
2. Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.
Tomoyasu T; Yamasaki T; Chiba S; Kusaka S; Tabata A; Whiley RA; Nagamune H
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28607101
[No Abstract] [Full Text] [Related]
3. LacR mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence.
Tomoyasu T; Imaki H; Masuda S; Okamoto A; Kim H; Waite RD; Whiley RA; Kikuchi K; Hiramatsu K; Tabata A; Nagamune H
Infect Immun; 2013 Sep; 81(9):3276-86. PubMed ID: 23798532
[TBL] [Abstract][Full Text] [Related]
4. Intermedilysin is essential for the invasion of hepatoma HepG2 cells by Streptococcus intermedius.
Sukeno A; Nagamune H; Whiley RA; Jafar SI; Aduse-Opoku J; Ohkura K; Maeda T; Hirota K; Miyake Y; Kourai H
Microbiol Immunol; 2005; 49(7):681-94. PubMed ID: 16034212
[TBL] [Abstract][Full Text] [Related]
5. Rapid screening method for detecting highly pathogenic Streptococcus intermedius strains carrying a mutation in the lacR gene.
Tomoyasu T; Matoba M; Takao A; Tabata A; Whiley RA; Maeda N; Nagamune H
FEMS Microbiol Lett; 2018 Feb; 365(3):. PubMed ID: 29228148
[TBL] [Abstract][Full Text] [Related]
6. Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.
Macey MG; Whiley RA; Miller L; Nagamune H
Infect Immun; 2001 Oct; 69(10):6102-9. PubMed ID: 11553548
[TBL] [Abstract][Full Text] [Related]
7. CcpA-dependent and -independent control of beta-galactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operon.
Kaufman GE; Yother J
J Bacteriol; 2007 Jul; 189(14):5183-92. PubMed ID: 17496092
[TBL] [Abstract][Full Text] [Related]
8. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
[TBL] [Abstract][Full Text] [Related]
9. Intermedilysin release by Streptococcus intermedius: effects of various antibacterial drugs at sub-MIC levels.
Taylor MB; Oh JH; Kang KL; Chow VT
FEMS Microbiol Lett; 2005 Feb; 243(2):379-84. PubMed ID: 15686838
[TBL] [Abstract][Full Text] [Related]
10. LuxS and expression of virulence factors in Streptococcus intermedius.
Pecharki D; Petersen FC; Scheie AA
Oral Microbiol Immunol; 2008 Feb; 23(1):79-83. PubMed ID: 18173802
[TBL] [Abstract][Full Text] [Related]
11. Intermedilysin induces EGR-1 expression through calcineurin/NFAT pathway in human cholangiocellular carcinoma cells.
Susilowati H; Okamura H; Hirota K; Shono M; Yoshida K; Murakami K; Tabata A; Nagamune H; Haneji T; Miyake Y
Biochem Biophys Res Commun; 2011 Jan; 404(1):57-61. PubMed ID: 21094139
[TBL] [Abstract][Full Text] [Related]
12. A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus.
Shelburne SA; Keith D; Horstmann N; Sumby P; Davenport MT; Graviss EA; Brennan RG; Musser JM
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1698-703. PubMed ID: 18230719
[TBL] [Abstract][Full Text] [Related]
13. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin.
Soltani CE; Hotze EM; Johnson AE; Tweten RK
J Biol Chem; 2007 May; 282(21):15709-16. PubMed ID: 17412689
[TBL] [Abstract][Full Text] [Related]
14. Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin.
Hu W; Ferris SP; Tweten RK; Wu G; Radaeva S; Gao B; Bronson RT; Halperin JA; Qin X
Nat Med; 2008 Jan; 14(1):98-103. PubMed ID: 18157141
[TBL] [Abstract][Full Text] [Related]
15. The catabolite control protein CcpA binds to Pmga and influences expression of the virulence regulator Mga in the Group A streptococcus.
Almengor AC; Kinkel TL; Day SJ; McIver KS
J Bacteriol; 2007 Dec; 189(23):8405-16. PubMed ID: 17905980
[TBL] [Abstract][Full Text] [Related]
16. Catabolite repression mediated by the catabolite control protein CcpA in Staphylococcus xylosus.
Egeter O; Brückner R
Mol Microbiol; 1996 Aug; 21(4):739-49. PubMed ID: 8878037
[TBL] [Abstract][Full Text] [Related]
17. Regulators of the Bacillus subtilis cydABCD operon: identification of a negative regulator, CcpA, and a positive regulator, ResD.
Puri-Taneja A; Schau M; Chen Y; Hulett FM
J Bacteriol; 2007 May; 189(9):3348-58. PubMed ID: 17322317
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
Ohkura K; Nagamune H; Kourai H
Anticancer Res; 2004; 24(5C):3343-53. PubMed ID: 15515430
[TBL] [Abstract][Full Text] [Related]
19. Catabolite regulation of the cytochrome c550-encoding Bacillus subtilis cccA gene.
Monedero V; Boël G; Deutscher J
J Mol Microbiol Biotechnol; 2001 Jul; 3(3):433-8. PubMed ID: 11361075
[TBL] [Abstract][Full Text] [Related]
20. A Flexible Binding Site Architecture Provides New Insights into CcpA Global Regulation in Gram-Positive Bacteria.
Yang Y; Zhang L; Huang H; Yang C; Yang S; Gu Y; Jiang W
mBio; 2017 Jan; 8(1):. PubMed ID: 28119470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]